Ribosomal protein L7 pseudogene 55 (RPL7P55)

Ribosomal protein L7 pseudogene 55 (RPL7P55) is a non-coding processed pseudogene in the human genome, meaning it is a DNA sequence similar to the functional ribosomal protein L7 gene (RPL7), but it does not encode a functional protein and does not possess biological activity[3][7][9]. Such pseudogenes are typically regarded as evolutionary remnants, often lacking regulatory elements, and are not considered therapeutic targets. RPL7P55 and other ribosomal protein L7 pseudogenes are annotated to distinguish them from their parent genes but do not have recognized roles in disease, drug targeting, or molecular function[3][7][9]. RPL7P55 is annotated in multiple gene and reagent databases as a pseudogene, with no reported protein product or biological function[3][7][9]. The functional RPL7 protein is a structural component of the large ribosomal subunit, but the pseudogenes (such as RPL7P55) do not perform this function[1][3][9]. Processed pseudogenes like RPL7P55 arise by retrotransposition and are typically inactive, though rare exceptions exist for pseudogenes in other contexts[2]. RPL7P55 does not fall into standard molecular target classes such as receptor, transporter, or enzyme, and is not referenced in disease, biomarker, or drug interaction contexts in available scientific resources[3][7][9]. There is no evidence RPL7P55 is a misspelling or confusion with a functional target, but as it is a pseudogene, "is_target" is false, and "is_incorrect" is true for therapeutic targeting purposes.

Other names

RPL7_32_1793RPL7P55